Clinical Trial
Accepted on 26 Jun 2025
Safety and Immunogenicity of a Recombinant Double-Mutant Heat-Labile Toxin (dmLT) Derived from Enterotoxigenic Escherichia coli (ETEC) in Healthy Bangladeshi Adults delivered by three different routes
in Pathogenesis, Vaccines, and Immunity of Bacterial Infections